Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhibition of virus-induced aggravation of childhood asthma by Salmeterol/Fluticasone Propionate Combination (SFC)
jRCTs031180304Active, not recruiting
- Start
- Oct 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised trial in asthma and asthma exacerbation comparing Fluticasone control group with Salmeterol/Fluticasone (SFC) group (2 arms). Primary endpoint: Asthma control during common cold episodes. Started Oct 2016; status: active, not recruiting.
02
Drugs
salmeterolfluticasone propionate
03
Conditions
asthmaasthma exacerbation
Beyond the preview
Go deeper on jRCTs031180304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180304.